eBook: Generic Pharma 2018
Generics step up to the plate, challenges and best practicies for manufacturing biosimilars and excipient trends
Prescription drug pricing has arguably become the biggest issue in U.S. healthcare. Generic drugs are a very viable solution. Thoroughly convinced of the unbelievable value proposition of their products, the generics industry is working to educate both the public and policymakers about generic/biosimilar drugs in order to restore the country’s balance between generic access and brand-name innovation.
This eBook will explore:
- Generic But Mighty: Generics step up to the plate
- Manufacturing biosimilars: challenges and best-practices
- Excipient trends: addressing bioequivalence and solubility challenges